SCHEMBL29973365

SCHEMBL29973365

COc1cc2nccc(Oc3ccc(C4(c5ccc(F)cc5)CC4(C(N)=O)C(N)=O)cc3)c2cc1OC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRA P16234 8/20 0.62
▸ KDR P35968 7/20 0.62
▸ MET P08581 7/20 0.61
▸ AXL P30530 7/20 0.61
▸ MERTK Q12866 3/20 0.61
▸ KIT P10721 2/20 0.61
▸ AURKA O14965 1/20 0.61
▸ RIPK2 O43353 1/20 0.61
▸ ABCB11 O95342 1/20 0.61
▸ ABL1 P00519 1/20 0.61
▸ EGFR P00533 1/20 0.61
▸ ERBB2 P04626 1/20 0.61
▸ NTRK1 P04629 1/20 0.61
▸ LCK P06239 1/20 0.61
▸ PGR P06401 1/20 0.61
▸ LYN P07948 1/20 0.61
▸ RET P07949 1/20 0.61
▸ CHRM2 P08172 1/20 0.61
▸ HCK P08631 1/20 0.61
▸ ADRA2A P08913 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23880322 0.81 PDGFRA (0.60) PDGFRAKDRMETAXLMERTK
SCHEMBL7487173 0.79 FGFR2 (0.76) PDGFRAKDRMETAXLMERTK
SCHEMBL8552659 0.79 PDGFRA (0.67) PDGFRAKDRMETAXLMERTK
SCHEMBL29883010 0.79 MET (0.66) PDGFRAKDRMETAXLMERTK
SCHEMBL372017 0.79 MET (0.66) PDGFRAKDRMETAXLMERTK
SCHEMBL901281 0.78 PDGFRA (0.68) PDGFRAKDRMETAXLMERTK
SCHEMBL16061581 0.77 MET (0.64) PDGFRAKDRMETAXLMERTK
Cabozantinib SCHEMBL18095042 0.77 AXL (0.98) KDRMETAXLMERTKKIT
SCHEMBL7479859 0.77 PDGFRA (1.00) PDGFRAKDRMETAXLMERTK
SCHEMBL410634 0.77 MET (0.58) PDGFRAKDRMETAXLMERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313048-A1 PROCESS FOR PREPARATION OF CABOZANTINIB Biocon Limited (IN) 2024-02-07 — — EP disclosed
WO-2022201079-A1 PROCESS FOR PREPARATION OF CABOZANTINIB BIOCON LIMITED (IN) 2022-09-29 — — WO disclosed
Send feedback